Next-generation CRISPR screens to fast-forward drug discovery
Our technology platform
At Myllia, we perform pooled CRISPR screens and functional genomics at scale in advanced cellular models to map the impact of thousands of genetic perturbations at single-cell resolution – a new paradigm to nominate the best possible targets for your drug discovery campaign. Our functional genomics platform enables tailor-made CRISPR screening:
CRISPR screening applications for drug discovery
Pooled CRISPR screens accelerate drug discovery across many therapeutic areas and help unravel gene regulatory networks in cancer cells and primary human T cells. We utilize CRISPR KO, CRISPRi and CRISPRa for genetic perturbation combined with high-throughput functional genomics read-outs. Learn more about CRISPR screening for various applications: